Immune escape of the human facultative pathogenic yeast Candida albicans: The many faces of the Candida Pra1 protein

International Journal of Medical Microbiology

Volumn 301, Issue 5, 2011, Pages 423-430

  Zipfel, Peter F ^a,b   Skerka, Christine ^a   Kupka, Danny ^a   Luo, Shanshan ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Complement; CRASPs; Human pathogenic fungi; Immune evasion; Innate immunity; Integrin

Indexed keywords

FUNGAL PROTEIN; MEMBRANE PROTEIN; PH REGULATED ANTIGEN 1; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CANDIDA ALBICANS; CANDIDIASIS; CELL SURFACE; CONTROLLED STUDY; FUNGAL VIRULENCE; FUNGUS IMMUNITY; HUMAN; INNATE IMMUNITY; MOLECULAR INTERACTION; NONHUMAN; SHORT SURVEY; YEAST;

CANDIDA ALBICANS; FUNGAL PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; VIRULENCE FACTORS;

EID: 79956338548     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2011.04.010     Document Type: Short Survey

References (58)

1. Agarwal V., Asmat T.M., Luo S., Jensch I., Zipfel P.F., Hammerschmidt S. Complement regulator factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J. Biol. Chem. 2010, 285:23486-23495.
2. Alonso-Valle H., Acha O., Garcia-Palomo J.D., Farinas-Alvarez C., Fernandez-Mazarrasa C., Farinas M.C. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22:254-257.
3. Angiolella L., Stringaro A.R., De Bernardis F., Posteraro B., Bonito M., Toccacieli L., Torosantucci A., Colone M., Sanguinetti M., Cassone A., Palamara A.T. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Antimicrob. Agents Chemother. 2008, 52:927-936.
4. Bailey D.A., Feldmann P.J., Bovey M., Gow N.A., Brown A.J. The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J. Bacteriol. 1996, 178:5353-5360.
5. Banerjee B., Kurup V.P., Phadnis S., Greenberger P.A., Fink J.N. Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Asp f II with significant immunoglobulin E reactivity in allergic bronchopulmonary aspergillosis. J. Lab. Clin. Med. 1996, 127:253-262.
6. Blom A.M., Villoutreix B.O., Dahlback B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?. Mol. Immunol. 2004, 40:1333-1346.
7. Calera J.A., Ovejero M.C., Lopez-Medrano R., Segurado M., Puente P., Leal F. Characterization of the Aspergillus nidulans aspnd1 gene demonstrates that the ASPND1 antigen, which it encodes, and several Aspergillus fumigatus immunodominant antigens belong to the same family. Infect. Immun. 1997, 65:1335-1344.
8. Casadevall A., Pirofski L.A. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect. Immun. 2000, 68:6511-6518.
9. Casanova M., Lopez-Ribot J.L., Monteagudo C., Llombart-Bosch A., Sentandreu R., Martinez J.P. Identification of a 58-kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect. Immun. 1992, 60:4221-4229.
10. Cheung A.L., Krishnan M., Jaffe E.A., Fischetti V.A. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J. Clin. Invest. 1991, 87:2236-2245.
11. Choi W., Yoo Y.J., Kim M., Shin D., Jeon H.B., Choi W. Identification of proteins highly expressed in the hyphae of Candida albicans by two-dimensional electrophoresis. Yeast 2003, 20:1053-1060.
12. Curtis M.M., Way S.S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 2009, 126:177-185.
13. Davis D., Wilson R.B., Mitchell A.P. RIM101-dependent and -independent pathways govern pH responses in Candida albicans. Mol. Cell. Biol. 2000, 20:971-978.
14. DiScipio R.G., Daffern P.J., Schraufstatter I.U., Sriramarao P. Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b/CD18). J. Immunol. 1998, 160:4057-4066.
15. Dobrina A., Pausa M., Fischetti F., Bulla R., Vecile E., Ferrero E., Mantovani A., Tedesco F. Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood 2002, 99:185-192.
16. Ferwerda G., Netea M.G., Joosten L.A., van der Meer J.W., Romani L., Kullberg B.J. The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans. Vaccine 2010, 28:614-622.
17. Flick M.J., Du X., Degen J.L. Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo. Exp. Biol. Med. (Maywood) 2004, 229:1105-1110.
18. Gantner B.N., Simmons R.M., Underhill D.M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 2005, 24:1277-1286.
19. Gomez M.J., Torosantucci A., Arancia S., Maras B., Parisi L., Cassone A. Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans. Infect. Immun. 1996, 64:2577-2584.
20. Gropp K., Schild L., Schindler S., Hube B., Zipfel P.F., Skerka C. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol. Immunol. 2009, 47:465-475.
21. Gudlaugsson O., Gillespie S., Lee K., Vande Berg J., Hu J., Messer S., Herwaldt L., Pfaller M., Diekema D. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 2003, 37:1172-1177.
22. Heinsbroek S.E., Brown G.D., Gordon S. Dectin-1 escape by fungal dimorphism. Trends Immunol. 2005, 26:352-354.
23. Hellwage J., Kuhn S., Zipfel P.F. The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity. Biochem. J. 1997, 326(Pt 2):321-327.
24. Jakab E., Paulsson M., Ascencio F., Ljungh A. Expression of vitronectin and fibronectin binding by Candida albicans yeast cells. APMIS 1993, 101:187-193.
25. Li B., Allendorf D.J., Hansen R., Marroquin J., Ding C., Cramer D.E., Yan J. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J. Immunol. 2006, 177:1661-1669.
26. Lopez-Ribot J.L., Sepulveda P., Cervera A.M., Roig P., Gozalbo D., Martinez J.P. Cloning of a cDNA fragment encoding part of the protein moiety of the 58-kDa fibrinogen-binding mannoprotein of Candida albicans. FEMS Microbiol. Lett. 1997, 157:273-278.
27. Lorenz M.C., Bender J.A., Fink G.R. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 2004, 3:1076-1087.
28. Luo S., Poltermann S., Kunert A., Rupp S., Zipfel P.F. Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein. Mol. Immunol. 2009, 47:541-550.
29. Luo S., Hartmann A., Dahse H.M., Skerka C., Zipfel P.F. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3. J. Immunol. 2010, 185:2164-2173.
30. Luo S., Blom A.M., Rupp S., Hipler U.C., Hube B., Skerka C., Zipfel P.F. The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J. Biol. Chem. 2011, 286:8021-8029.
31. Marcil A., Gadoury C., Ash J., Zhang J., Nantel A., Whiteway M. Analysis of PRA1 and its relationship to Candida albicans-macrophage interactions. Infect. Immun. 2008, 76:4345-4358.
32. Medzhitov R., Janeway C. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 2000, 173:89-97.
33. Medzhitov R., Janeway C. Innate immunity. N. Engl. J. Med. 2000, 343:338-344.
34. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 1993, 11:165-190.
35. Netea M.G., Sutmuller R., Hermann C., Van der Graaf C.A., Van der Meer J.W., van Krieken J.H., Hartung T., Adema G., Kullberg B.J. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 2004, 172:3712-3718.
36. Nordahl E.A., Rydengard V., Nyberg P., Nitsche D.P., Morgelin M., Malmsten M., Bjorck L., Schmidtchen A. Activation of the complement system generates antibacterial peptides. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16879-16884.
37. Pappas P.G., Rex J.H., Lee J., Hamill R.J., Larsen R.A., Powderly W., Kauffman C.A., Hyslop N., Mangino J.E., Chapman S., Horowitz H.W., Edwards J.E., Dismukes W.E. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. Infect. Dis. 2003, 37:634-643.
38. Phan Q.T., Myers C.L., Fu Y., Sheppard D.C., Yeaman M.R., Welch W.H., Ibrahim A.S., Edwards J.E., Filler S.G. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 2007, 5:e64.
39. Poltermann S., Kunert A., von der Heide M., Eck R., Hartmann A., Zipfel P.F. Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans. J. Biol. Chem. 2007, 282:37537-37544.
40. Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 2001, 276:37692-37699.
41. Ricklin D., Lambris J.D. Compstatin: a complement inhibitor on its way to clinical application. Adv. Exp. Med. Biol. 2008, 632:273-292.
42. Rosen H., Law S.K. The leukocyte cell surface receptor(s) for the iC3b product of complement. Curr. Top. Microbiol. Immunol. 1990, 153:99-122.
43. Ross G.D., Vetvicka V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol. 1993, 92:181-184.
44. Santoni G., Spreghini E., Lucciarini R., Amantini C., Piccoli M. Involvement of alpha(v)beta3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and to a human endothelial cell line. Microb. Pathog. 2001, 31:159-172.
45. Schaller M., Borelli C., Korting H.C., Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005, 48:365-377.
46. Sentandreu M., Elorza M.V., Sentandreu R., Fonzi W.A. Cloning and characterization of PRA1, a gene encoding a novel pH-regulated antigen of Candida albicans. J. Bacteriol. 1998, 180:282-289.
47. Sohn K., Senyürek I., Fertey J., Königsdorfer A., Joffroy C., Hauser N., Zelt G., Brunner H., Rupp S. An in vitro assay to study the transcriptional response during adherence of Candida albicans to different human epithelia. FEMS Yeast Res. 2006, 6:1085-1093.
48. Soloviev D.A., Fonzi W.A., Sentandreu R., Pluskota E., Forsyth C.B., Yadav S., Plow E.F. Identification of pH-regulated antigen 1 released from Candida albicans as the major ligand for leukocyte integrin alphaMbeta2. J. Immunol. 2007, 178:2038-2046.
49. Sonesson A., Ringstad L., Nordahl E.A., Malmsten M., Morgelin M., Schmidtchen A. Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim. Biophys. Acta 2007, 1768:346-353.
50. Torosantucci A., Bromuro C., Gomez M.J., Ausiello C.M., Urbani F., Cassone A. Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans. J. Infect. Dis. 1993, 168:427-435.
51. Ullmann B.D., Myers H., Chiranand W., Lazzell A.L., Zhao Q., Vega L.A., Lopez-Ribot J.L., Gardner P.R., Gustin M.C. Inducible defense mechanism against nitric oxide in Candida albicans. Eukaryot. Cell 2004, 3:715-723.
52. van Bruggen R., Drewniak A., Jansen M., van Houdt M., Roos D., Chapel H., Verhoeven A.J., Kuijpers T.W. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol. Immunol. 2009, 47:575-581.
53. Viudes A., Perea S., Lopez-Ribot J.L. Identification of continuous B-cell epitopes on the protein moiety of the 58-kiloDalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens. Infect. Immun. 2001, 69:2909-2919.
54. Wellington M., Dolan K., Krysan D.J. Live Candida albicans suppresses production of reactive oxygen species in phagocytes. Infect. Immun. 2009, 77:405-413.
55. Wilson D., Hube B. Hgc1 mediates dynamic Candida albicans-endothelium adhesion events during circulation. Eukaryot. Cell 2010, 9:278-287.
56. Zipfel P.F., Jokiranta T.S., Hellwage J., Koistinen V., Meri S. The factor H protein family. Immunopharmacology 1999, 42:53-60.
57. Zipfel P.F., Wurzner R., Skerka C. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol. Immunol. 2007, 44:3850-3857.
58. Zipfel P.F., Reuter M. Complement activation products C3a and C4a as endogenous antimicrobial peptides. Int. J. Peptide Res. Therapeutics 2009, 15:87-95.